Protocol Title: An Open-Label Phase 2 Proof-Of-Concept Study In Patients With C3 Glomerulopathy (C3g) Or Immune- Complex Membranoproliferative Glomerulonephritis (Icmpgn) Treated With Ach-0144471 (Ach471-205)

Clinical Study Identifier: TX6028

Contact research investigator to learn more about this study by filling out the form below.

To: Research Study Investigator
Subject: I am interested in participating in your Research Study
Dear Investigator,
I'm interested in learning more about and participating in your research study named: Protocol Title: An Open-label Phase 2 Proof-of-Concept Study in Patients with C3 Glomerulopathy (C3G) or Immune- Complex Membranoproliferative Glomerulonephritis (ICMPGN) Treated with ACH-0144471 (ACH471-205)
I am hoping to hear back from you and discuss details of the study

By clicking "Contact Research Team", your contact information will be sent directly to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.